How to Better Establish Clinical Utility for Tests in Personalized Medicine

Gary Palmer, MD

Video Categories: Personalized Medicine

Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.

Related Videos

October 23, 2018

Creating a Paradigm for Biomarker Testing

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider the advantages and disadvantages of liquid biopsies as an early screening tool for biomarker testing, and how to integrate various approaches into a biomarker testing paradigm.

July 13, 2021

Significance of Early and Broad Testing of Tumor Mutations

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, discuss how testing for tumor mutations early and broadly may lead to better treatment outcomes.